Business · 27/12/2004Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Pharmacogenomics Data Submission Guidance
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on its guidance for the submission of pharmacogenomics data, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →